Raghava Reddy Kethiri

2 Patents

• US119256292024

  Heterocyclic Inhibitors of ERK1 and ERK2 and Their Use in the Treatment of Cancer

  ASANA BIOSCIENCES, LLC

  0 cites
• US115477042023

  Chemical Compounds

  Glaxosmithkline Intellectual Property Development Limited

  0 cites